MAZZIOTTI, Gherardo
 Distribuzione geografica
Continente #
NA - Nord America 4.635
AS - Asia 1.963
EU - Europa 1.839
SA - Sud America 343
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 8.840
Nazione #
US - Stati Uniti d'America 4.571
SG - Singapore 728
CN - Cina 711
UA - Ucraina 427
PL - Polonia 364
BR - Brasile 293
DE - Germania 270
HK - Hong Kong 185
FI - Finlandia 168
FR - Francia 136
GB - Regno Unito 123
IT - Italia 111
VN - Vietnam 89
RU - Federazione Russa 78
TR - Turchia 68
IN - India 66
IE - Irlanda 65
CA - Canada 37
BD - Bangladesh 28
AR - Argentina 21
CZ - Repubblica Ceca 19
MX - Messico 19
SE - Svezia 18
ZA - Sudafrica 17
ES - Italia 13
IQ - Iraq 13
NL - Olanda 12
ID - Indonesia 11
BE - Belgio 10
JP - Giappone 10
NG - Nigeria 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
VE - Venezuela 8
EU - Europa 7
CL - Cile 6
IR - Iran 6
MA - Marocco 6
AU - Australia 5
KE - Kenya 5
KR - Corea 5
AT - Austria 4
JM - Giamaica 4
PE - Perù 4
PK - Pakistan 4
RO - Romania 4
AL - Albania 3
CO - Colombia 3
EC - Ecuador 3
NP - Nepal 3
AM - Armenia 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
GE - Georgia 2
IL - Israele 2
JO - Giordania 2
KW - Kuwait 2
LT - Lituania 2
PA - Panama 2
PS - Palestinian Territory 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CM - Camerun 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
NR - Nauru 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TG - Togo 1
TH - Thailandia 1
Totale 8.840
Città #
Fairfield 644
Ashburn 513
Singapore 384
Warsaw 358
Houston 342
Woodbridge 316
Jacksonville 290
Seattle 248
Cambridge 234
Ann Arbor 215
Wilmington 199
Beijing 191
Hong Kong 185
San Jose 171
The Dalles 133
Chandler 124
Princeton 118
Nanjing 103
New York 97
Helsinki 96
Los Angeles 74
Dublin 64
Lauterbourg 59
Istanbul 57
Nanchang 51
Munich 48
Dallas 47
Moscow 38
Des Moines 36
Shenyang 31
San Diego 30
Brescia 29
Shanghai 27
Buffalo 26
Council Bluffs 25
São Paulo 24
Ho Chi Minh City 23
San Francisco 23
Chicago 22
Redondo Beach 22
Orem 21
Changsha 20
Jiaxing 20
Tianjin 20
Milan 19
London 17
Mumbai 17
Hebei 16
Washington 16
Hanoi 15
Toronto 15
Boardman 14
Brno 14
Manchester 14
Poplar 14
Rio de Janeiro 14
Santa Clara 14
Turku 14
Atlanta 12
Denver 12
Dong Ket 12
Kunming 12
Hangzhou 11
Brussels 10
Tokyo 10
Augusta 9
Brooklyn 9
Chennai 9
Abuja 8
Dhaka 8
Johannesburg 8
Montreal 8
San Mateo 8
Stockholm 8
Ankara 7
Belo Horizonte 7
Cassina de' Pecchi 7
Lancaster 7
Mexico City 7
Philadelphia 7
Baghdad 6
Charlotte 6
Curitiba 6
Greifswald 6
Jakarta 6
Leawood 6
Paris 6
Tashkent 6
Brasília 5
Frankfurt am Main 5
Jinan 5
Lappeenranta 5
Monmouth Junction 5
Querétaro 5
Vancouver 5
Ardabil 4
Bari 4
Boston 4
Calcinate 4
Caracas 4
Totale 6.310
Nome #
High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome 348
Elevated intraocular pressure in patients with acromegaly 338
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 192
Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. 183
Growth hormone deficiency in treated acromegaly 181
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 181
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 172
Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism. 164
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. 152
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 152
Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis 149
Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. 148
Cardiovascular risk in aging and obesity: is there a role for GH. 144
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review. 143
ASSOCIATION BETWEEN L-THYROXINE TREATMENT, GH DEFICIENCY, AND RADIOLOGICAL VERTEBRAL FRACTURES IN PATIENTS WITH ADULT-ONSET HYPOPITUITARISM. 143
Growth hormone deficiency in the adult. 140
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. 139
Prevalence of vertebral fractures in men with acromegaly 138
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 138
Octreotide for acromegaly treatment: a reappraisal. 138
New understanding and treatments for osteoporosis. 136
VERTEBRAL FRACTURES IN PATIENTS WITH ACROMEGALY: A 3 - YEAR PROSPECTIVE STUDY 136
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. 135
Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. 134
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 134
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. 133
Glucocorticoids and the regulation of growth hormone secretion. 132
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects. 130
Active acromegaly enhances spontaneous parathyroid hormone pulsatility. 129
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 128
Cushing's syndrome and bone. 123
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 121
Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. 120
High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. 119
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 117
GH deficiency in the adult and bone. 117
Commentary:Postsurgical monitoring of acromegaly 116
Growth hormone replacement therapy and fracture risk 116
Treatment with metformin is protective against limitations in instrumental activities of daily living in older subjects with type 2 diabetes mellitus. 116
Osteoporosis in HIV patients: an emerging clinical issue 115
Vertebral fractures in males with prolactinoma. 115
Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects. 114
High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone-Suppressive Therapy for Thyroid Carcinoma 114
Pituitary diseases and bone 114
Subclinical thyrotoxicosis and bone 113
Growth hormone, insulin like growth factors, and the skeleton 112
Glucocorticoid-induced osteoporosis: pathophysiology and therapy. 111
Glucocorticoid-induced osteoporosis: an update. 111
Molecular imaging in acromegaly: should clinicians look carefully at developments in the field? 110
Meta-analysis on the effects of octreotide on tumor mass in acromegaly. 108
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. 107
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA. 105
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies 105
Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome 104
Prevention and treatment of glucocorticoid-induced osteoporosis. 103
Diagnosis and treatment of acromegaly and its complications: consensus guidelines. 103
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 100
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 100
Resistance to somatostatin analogs in acromegaly: an evolving concept? 100
Drug-induced osteoporosis:mechanism and clinical implications 97
Glucocorticoid-induced osteoporosis and parathyroid hormone. 97
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 94
Glucocorticoid replancement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 88
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 87
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice 82
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 72
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 69
Growth Hormone Insuline like Growth Factor-1, and the Kidney Pathophysiological and Clinical Implication 66
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 61
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool 44
null 13
Totale 8.909
Categoria #
all - tutte 38.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.969


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021301 0 0 0 0 0 0 0 0 0 123 150 28
2021/2022511 43 105 10 15 5 25 26 32 23 54 39 134
2022/2023401 69 2 2 22 48 119 1 32 66 2 16 22
2023/2024584 28 14 42 54 42 114 26 17 136 6 6 99
2024/20251.109 6 3 12 156 135 91 58 51 144 43 268 142
2025/20262.149 261 297 144 261 324 175 389 53 140 105 0 0
Totale 8.909